Teva Pharmaceutical Industries Limited (TEVA) Stake Reduced by Town & Country Bank & Trust CO dba First Bankers Trust CO

Town & Country Bank & Trust CO dba First Bankers Trust CO lowered its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) by 1.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,765 shares of the company’s stock after selling 100 shares during the period. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in Teva Pharmaceutical Industries Limited were worth $225,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Cribstone Capital Management LLC raised its position in Teva Pharmaceutical Industries Limited by 3.3% in the first quarter. Cribstone Capital Management LLC now owns 3,141 shares of the company’s stock valued at $101,000 after buying an additional 100 shares during the last quarter. Bronfman E.L. Rothschild L.P. raised its position in Teva Pharmaceutical Industries Limited by 7.8% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 3,617 shares of the company’s stock valued at $116,000 after buying an additional 261 shares during the last quarter. FNY Managed Accounts LLC bought a new position in Teva Pharmaceutical Industries Limited during the first quarter valued at about $123,000. Sterling Investment Advisors Ltd. raised its position in Teva Pharmaceutical Industries Limited by 2.6% in the first quarter. Sterling Investment Advisors Ltd. now owns 3,900 shares of the company’s stock valued at $125,000 after buying an additional 100 shares during the last quarter. Finally, Financial Architects Inc raised its position in shares of Teva Pharmaceutical Industries Limited by 2.3% in the first quarter. Financial Architects Inc now owns 4,443 shares of the company’s stock valued at $143,000 after buying an additional 100 shares in the last quarter. Institutional investors own 56.27% of the company’s stock.

Teva Pharmaceutical Industries Limited (NYSE TEVA) traded down 1.61% during midday trading on Tuesday, reaching $18.29. The company had a trading volume of 51,308,881 shares. Teva Pharmaceutical Industries Limited has a 12-month low of $18.21 and a 12-month high of $55.45. The stock’s 50 day moving average is $32.05 and its 200 day moving average is $32.28. The firm has a market capitalization of $18.58 billion, a price-to-earnings ratio of 234.49 and a beta of 0.46.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $0.99 EPS for the quarter, missing the Zacks’ consensus estimate of $1.06 by $0.07. The business had revenue of $5.69 billion for the quarter, compared to the consensus estimate of $5.72 billion. Teva Pharmaceutical Industries Limited had a positive return on equity of 15.96% and a negative net margin of 25.18%. The business’s revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.25 earnings per share. Equities research analysts expect that Teva Pharmaceutical Industries Limited will post $4.44 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 14th. Investors of record on Tuesday, August 29th will be issued a dividend of $0.085 per share. The ex-dividend date is Friday, August 25th. This represents a $0.34 dividend on an annualized basis and a yield of 1.86%. Teva Pharmaceutical Industries Limited’s dividend payout ratio (DPR) is currently -18.95%.

COPYRIGHT VIOLATION WARNING: “Teva Pharmaceutical Industries Limited (TEVA) Stake Reduced by Town & Country Bank & Trust CO dba First Bankers Trust CO” was first reported by BBNS and is owned by of BBNS. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://baseballnewssource.com/markets/teva-pharmaceutical-industries-limited-teva-stake-decreased-by-town-country-bank-trust-co-dba-first-bankers-trust-co-updated-updated-updated/1196027.html.

Several brokerages recently issued reports on TEVA. Credit Suisse Group set a $39.00 price objective on Teva Pharmaceutical Industries Limited and gave the company a “buy” rating in a research report on Thursday, August 3rd. Cantor Fitzgerald set a $31.00 price objective on Teva Pharmaceutical Industries Limited and gave the company a “hold” rating in a research report on Thursday, June 22nd. Vetr upgraded Teva Pharmaceutical Industries Limited from a “hold” rating to a “buy” rating and set a $34.17 price objective for the company in a research report on Monday, July 24th. Zacks Investment Research upgraded Teva Pharmaceutical Industries Limited from a “sell” rating to a “hold” rating in a research report on Monday, July 17th. Finally, BidaskClub lowered Teva Pharmaceutical Industries Limited from a “hold” rating to a “sell” rating in a research report on Tuesday. Two research analysts have rated the stock with a sell rating, twenty-one have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $38.60.

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams.

Institutional Ownership by Quarter for Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Receive News & Ratings for Teva Pharmaceutical Industries Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teva Pharmaceutical Industries Limited and related companies with our FREE daily email newsletter.

 


Latest News

Los Angeles Dodgers Alex Wood Has Shoulder Inflammation
Los Angeles Dodgers Alex Wood Has Shoulder Inflammation
Blues Jays Ready to Take Flight
Blues Jays Ready to Take Flight
Umpires Ending Protest Over Incident With Ian Kinsler
Umpires Ending Protest Over Incident With Ian Kinsler
Kris Bryant Back in Spotlight, Cubs Pushing for Playoff Berth
Kris Bryant Back in Spotlight, Cubs Pushing for Playoff Berth
Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts


Leave a Reply

 
© 2006-2017 BBNS.